至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Hybrid fusion protein as a dual protease inhibitor for the healing of chronic wounds

Biotechnol Prog. 2021-09; 
Graham Strauss, Piyush Koria
Products/Services Used Details Operation
Gene Synthesis … The nucleic acid sequences for the three amino acid sequences used to create PMP-D2۰L10FLAG۰APP-IP were obtained in plasmid form in pUC19 or pUC57 from GenScript®. The gene for PMPD2-L10FLAG-APP-IP was constructed by … Get A Quote

摘要

Diseases bring about the need for interventions that pinpoint each specific aspect of the illness. Commonly, remission of a complex disease is accomplished by mixing treatments, medications, and therapeutics together in a fashion where they may negatively interact with each other or never arrive at the diseased site as a systemic heterogeneous mixture. Chronic wounds display intricacy as they are very localized and have their own environment where tissue deconstruction due to high levels of numerous proteases outweighs normal tissue reconstruction. This idea leads to the necessity of a protein that contains low diffusivity rates for localized treatment, strength against high concentrations of proteolytic specie... More

关键词

combination therapy, elastin-like peptide, multifunctional proteins, protease inhibitor, wound healing